Investment
Features
FeesSafety
Academy
More
Pluang+

Owlting and Decaf launch U.S. dollar accounts for non-U.S. businesses via OwlPay Harbor

Market News
14 Oct 2026
GlobeNewsWire
View Source
Bullish
Owlting and Decaf launch U.S. dollar accounts for non-U.S. businesses via OwlPay Harbor

Owlting Group and Decaf have integrated to offer U.S. dollar accounts to eligible businesses outside the U.S. through the OwlPay Harbor platform. This service allows companies to hold, fund, and pay in U.S. dollars without needing a U.S. entity, streamlining cross-border payments especially in dollar-dependent regions like Latin America. The platform supports payments via wire, ACH, RTP, and Visa Direct, and is already used by diverse organizations including exporters and humanitarian groups. Owlting plans to expand payout capabilities and expects more platforms to adopt OwlPay Harbor, targeting over $1 billion in processed payment volume by end of 2026.

The story about Owlting Group and Decaf's new U.S. dollar accounts service is presented with Financials-sector market data from Pluang. For readers following this sector, as of Oct 14, 2026 17:11 WIB, 88 of 142 priced Financials-sector US stocks rose while 43 fell. Notable movers include Mizuho Financial Group Inc. ADR at USD 10.35 with a 1-day change of -2.36%, Genworth Financial Inc. at USD 8.72 down 1.91%, and Mitsubishi UFJ Financial Group Inc. at USD 22.05 with a 1-day change of -1.56% and 100% sell order activity on Pluang.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App